Market revenue in 2023 | USD 10.2 million |
Market revenue in 2030 | USD 19.1 million |
Growth rate | 9.4% (CAGR from 2023 to 2030) |
Largest segment | Radiofrequency ablation |
Fastest growing segment | Microwave Ablation |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Radiofrequency Ablation, Microwave Ablation |
Key market players worldwide | Boston Scientific Corp, BVM Medical, Integra Lifesciences Holdings Corp, Johnson & Johnson, Medtronic PLC, Olympus Corp, Terumo Corp, Theraclion, Medwave, StarMed |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to thyroid ablation devices market will help companies and investors design strategic landscapes.
Radiofrequency ablation was the largest segment with a revenue share of 49.02% in 2023. Horizon Databook has segmented the UK thyroid ablation devices market based on radiofrequency ablation, microwave ablation covering the revenue growth of each sub-segment from 2018 to 2030.
The UK thyroid ablation devices market is anticipated to experience lucrative growth over the forecast period. Extensive R&D spending by the UK Government is anticipated to help formulate control measures against increasing cases of thyroid cancer.
NHS announced the launch of early diagnosis program in partnership with Macmillan Cancer Support and Cancer Research UK. Furthermore, it announced the extension of commission toward innovative stereotactic ablative therapy and radiotherapy treatments.
Such supportive initiatives are anticipated to propel the market in this country. Furthermore, the National Institute for Health and Care Excellence (NICE) in the UK has issued a document titled "Interventional Procedures Guidance [IPG743]" that outlines recommendations for the utilization of a percutaneous ultrasound-guided microwave ablation system for the treatment of symptomatic benign thyroid nodules.
Horizon Databook provides a detailed overview of country-level data and insights on the UK thyroid ablation devices market , including forecasts for subscribers. This country databook contains high-level insights into UK thyroid ablation devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account